ArticleCancer immunology research2017
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.
Jun Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
231 papers cite itlatest 60 shown
this paperpooled ittrialcites it